DHR vs MELI: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and MercadoLibre, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
MercadoLibre, Inc. · Consumer Cyclical
$1,635.15
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
MELI has more upside to fair value
(+45.0%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MELI |
| Current Price |
$195.98 |
$1,635.15 |
| Fair Value Estimate |
$211.54 |
$2,370.97 |
| Upside to Fair Value |
+7.9%
|
+45.0%
|
| Market Cap |
$138.7B |
$82.9B |
| Forward P/E |
37.8x
|
43.2x
|
| EV / EBITDA |
22.8x
|
27.0x
|
| Price / Sales |
5.6x
|
2.6x
|
| Price / FCF |
26.2x
|
7.7x
|
| Revenue Growth YoY |
+3.7%
|
+49.0%
|
| Gross Margin |
60.7%
|
43.9%
|
| Operating Margin |
21.0%
|
9.6%
|
| Return on Equity |
7.1%
|
29.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
12.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
MercadoLibre is a leading Latin American e-commerce and fintech platform with a durable competitive moat driven by its integrated logistics and financial services stack. The company commands approximately 30 to 35 percent market share in e-commerce and over 30 percent in online payments in key markets like Brazil. It is founder-influenced with a long-tenured management team and reinvests heavily …
Accumulation Zones
| Metric |
DHR |
MELI |
| Zone Low |
$158.66 |
$1,778.23 |
| Zone High |
$179.81 |
$2,015.32 |
| In Buy Zone? |
No
|
Yes
|